Virbac SA
PAR:VIRP

Watchlist Manager
Virbac SA Logo
Virbac SA
PAR:VIRP
Watchlist
Price: 334.5 EUR -0.74% Market Closed
Market Cap: 2.8B EUR
Have any thoughts about
Virbac SA?
Write Note

Virbac SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Virbac SA
Cost of Revenue Peer Comparison

Comparables:
SAN
IPN
VETO
BOI
MEDCL

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Virbac SA
PAR:VIRP
Cost of Revenue
-€450.3m
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Sanofi SA
PAR:SAN
Cost of Revenue
-€18.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Cost of Revenue
-€618m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
Vetoquinol SA
PAR:VETO
Cost of Revenue
-€275.1m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-5%
Boiron SA
PAR:BOI
Cost of Revenue
-€130.8m
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
0%
Medincell SA
PAR:MEDCL
Cost of Revenue
-€2.3m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A

See Also

What is Virbac SA's Cost of Revenue?
Cost of Revenue
-450.3m EUR

Based on the financial report for Jun 30, 2024, Virbac SA's Cost of Revenue amounts to -450.3m EUR.

What is Virbac SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%

Over the last year, the Cost of Revenue growth was 31%. The average annual Cost of Revenue growth rates for Virbac SA have been 4% over the past three years , 1% over the past five years , and -2% over the past ten years .

Back to Top